The road to lenacapavir, a breakthrough HIV treatment
In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful.
Today, thanks to that sequence of contributions, the first HIV drug to offer long-lasting protection from infection — eliminating the need for people to take a daily pill — exists. For their role in ensuring that drug, lenacapavir, came to life and to market, the AAAS Mani L. Bhaumik Breakthrough of the Year Award is being awarded to Wesley Sundquist, chair of the University of Utah Department of Biochemistry; Moupali Das, vice president, Clinical Development, HIV Prevention ...